Ads
related to: tumor markers for hepatocellular carcinoma- uHCC Treatment Option
Patients: Learn More About A
Hepatocellular Carcinoma Treatment.
- Plan for uHCC Treatment
Diagnosis Can Be A Shock. Learn
How To Prepare For uHCC Treatment.
- Patient & Caregiver Info
Learn More About uHCC & A
Treatment Option That Could Help.
- uHCC Patient Information
Recently Diagnosed With uHCC?
Learn More About A Treatment Option
- Talk To Your Doctor
Learn How To Start The Conversation
About A uHCC Treatment Option.
- uHCC Treatment Website
Visit Patients & Caregiver Site
To Learn About A Treatment Option.
- uHCC Treatment Option
Search results
Results From The WOW.Com Content Network
As with any cancer, the treatment and prognosis of HCC varies depending on tumor histology, size, how far the cancer has spread, and overall health of the person. The vast majority of HCC cases and the lowest survival rates after treatment occur in Asia and sub-Saharan Africa , in countries where hepatitis B infection is endemic and many are ...
Transformation to hepatocellular carcinoma is more common in men. [2] ... rising level of liver tumor markers such as alpha fetoprotein, the patient is a male, ...
A tumor marker is a biomarker that can be used to indicate the presence of cancer or the behavior of ... germ cell tumor, hepatocellular carcinoma [9] CA15-3: breast ...
Liver tumor types by relative incidence in adults in the United States (liver cancers in dark red color). [14] The most frequent liver cancer, accounting for approximately 75% of all primary liver cancers, is hepatocellular carcinoma (HCC). [15] HCC is a cancer formed by liver cells, known as hepatocytes, that become malignant. In terms of ...
Clinical evaluation of lentil lectin-reactive alpha-fetoprotein-L3 in histology-proven hepatocellular carcinoma. Khien VV, et al., Int J Biol Markers. 2001 Apr-Jun;16(2):105-11. Usefulness of measurement of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and recurrence of small hepatocellular carcinoma.
Tumor antigen is an antigenic substance produced in tumor cells, i.e., it triggers an immune response in the host. Tumor antigens are useful tumor markers in identifying tumor cells with diagnostic tests and are potential candidates for use in cancer therapy. The field of cancer immunology studies such topics.
Ads
related to: tumor markers for hepatocellular carcinoma